Aytu Biopharma AYTU
NASDAQ AYTU
$2.07 -0.02 (-0.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Selling, General & Administrative (2010 - 2026)

Updated

Aytu Biopharma's Selling, General & Administrative was $4.31 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 16.5% from $3.7 million a year earlier but down 13.4% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Selling, General & Administrative at Aytu Biopharma came in at $19.27 million, up 10.9% from FY2025.

  • Selling, General & Administrative shows a five-year compound annual growth rate of -5.4% (FY2021 to FY2026).
  • In earlier fiscal years, Selling, General & Administrative was $17.38 million in FY2025 (-12.9%), $19.95 million in FY2024 (-30.3%), $28.63 million in FY2023 (-8.1%) and $31.17 million in FY2022 (+22.2%).
  • Quarterly Selling, General & Administrative has moved between $3.7 million (fiscal Q4 2025) and $8.22 million (fiscal Q1 2022) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with an average decline of 0.2% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q1 2022 (growth of 51.6%); the worst was fiscal Q2 2024 (a decline of 40.1%).
  • Per Business Quant data, AYTU's Selling, General & Administrative in the three fiscal quarters before Q4 2026 was $4.97 million (Q3 2026), $5.07 million (Q2 2026) and $4.92 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Aytu Biopharma 22.49 Mn -93.18 Mn 10.41 Mn 4.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.31 Mn
Mar 31, 2026 4.97 Mn
Dec 31, 2025 5.07 Mn
Sep 30, 2025 4.92 Mn
Jun 30, 2025 3.70 Mn
Mar 31, 2025 4.11 Mn
Dec 31, 2024 4.45 Mn
Sep 30, 2024 5.13 Mn
Jun 30, 2024 4.03 Mn
Mar 31, 2024 4.83 Mn
Dec 31, 2023 4.80 Mn
Sep 30, 2023 6.30 Mn
Jun 30, 2023 6.11 Mn
Mar 31, 2023 7.18 Mn
Dec 31, 2022 8.02 Mn
Sep 30, 2022 7.32 Mn
Jun 30, 2022 7.38 Mn
Mar 31, 2022 7.62 Mn
Dec 31, 2021 7.95 Mn
Sep 30, 2021 8.22 Mn
API Access

Aytu Biopharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AYTU&period=max&api_key=YOUR_API_KEY